Project Details
Description
A non-interventional extension study for patients treated in study R5459-RT-1944 with REGN5459 or REGEN5458 (BCMAxCD3 bispecific antibodies [bsAbs]) that receive a kidney transplant
| Status | Active |
|---|---|
| Effective start/end date | 8/6/24 → 12/31/26 |
Funding
- REGENERON PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.